ES483558A1 - Procedimiento para la obtencion de derivados de sililgluco- saminas - Google Patents

Procedimiento para la obtencion de derivados de sililgluco- saminas

Info

Publication number
ES483558A1
ES483558A1 ES483558A ES483558A ES483558A1 ES 483558 A1 ES483558 A1 ES 483558A1 ES 483558 A ES483558 A ES 483558A ES 483558 A ES483558 A ES 483558A ES 483558 A1 ES483558 A1 ES 483558A1
Authority
ES
Spain
Prior art keywords
lower alkyl
hydrogen
alkyl
carbon atoms
mean
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES483558A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27173419&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES483558(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of ES483558A1 publication Critical patent/ES483558A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
    • C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
    • C07H9/04—Cyclic acetals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H23/00—Compounds containing boron, silicon or a metal, e.g. chelates or vitamin B12
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/005—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55583—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6062—Muramyl peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Procedimiento para la obtención de derivados de sililglucosaminas de fórmula (I) donde X significa un grupo carbonilo, R1, R4 y R6 significan tri-alquilo inferior-sililo, en primer lugar trimetilsililo, R2 significa alquilo, en caso dado sustituido, o arilo carbocíclico, R3 significa hidrógeno o alquilo, R7 y R13 significan hidrógeno o alquilo inferior, R8 significa hidrógeno, alquilo inferior, hidroxi-alquilo inferior libre o funcionalmente modificado, mercapto-alquilo inferior libre o funcionalmente modificado, mercapto-alquilo inferior, halógeno-alquilo inferior, cicloalquilo con 5 ó 6 átomos de carbono, cicloalquil- alquilo inferior, cuyo resto cicloalquilo contiene 5 ó 6 átomos de carbono, arilo o aralquilo, en caso dado sustituido, heterocíclilo conteniendo nitrógeno o heterociclilo-alquilo inferior, R7 y R8 juntos también significan alquileno con 3 ó 4 átomos de carbono, R9 significa hidrógeno o alquilo inferior y los restos R10, R11 y R12 independientes entre sí significan un restocarboxi en caso dado esterificado o amidado, y R11 también significa hidrógeno.
ES483558A 1978-02-24 1979-08-22 Procedimiento para la obtencion de derivados de sililgluco- saminas Expired ES483558A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH203578 1978-02-24
CH377778 1978-04-07
CH539478 1978-05-18

Publications (1)

Publication Number Publication Date
ES483558A1 true ES483558A1 (es) 1980-04-16

Family

ID=27173419

Family Applications (2)

Application Number Title Priority Date Filing Date
ES477977A Expired ES477977A1 (es) 1978-02-24 1979-02-22 Procedimiento para la obtencion de nuevos derivados de anti-geno.
ES483558A Expired ES483558A1 (es) 1978-02-24 1979-08-22 Procedimiento para la obtencion de derivados de sililgluco- saminas

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES477977A Expired ES477977A1 (es) 1978-02-24 1979-02-22 Procedimiento para la obtencion de nuevos derivados de anti-geno.

Country Status (20)

Country Link
EP (1) EP0003833B2 (es)
JP (1) JPS54141718A (es)
AR (1) AR223833A1 (es)
AT (1) AT364718B (es)
AU (1) AU527549B2 (es)
CA (1) CA1138436A (es)
DD (1) DD141616A5 (es)
DK (1) DK161026C (es)
ES (2) ES477977A1 (es)
FI (1) FI66878C (es)
GB (1) GB2015534A (es)
GR (1) GR77615B (es)
HU (1) HU182011B (es)
IL (1) IL56724A (es)
NO (2) NO151201C (es)
NZ (1) NZ189756A (es)
PL (1) PL123315B1 (es)
PT (1) PT69281A (es)
SU (1) SU1055312A3 (es)
ZA (1) ZA79893B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54130516A (en) * 1978-03-31 1979-10-09 Yuuichi Yamamura Acyllnnacetylmuramylpeptide derivativeeantigen combination
FR2428051A1 (fr) * 1978-06-05 1980-01-04 Anvar Nouveaux composes du type muramyl-peptide et medicaments les contenant
FR2428050A1 (fr) * 1978-06-05 1980-01-04 Anvar Oligomeres de composes du type muramyl-peptide et medicaments les contenant
DE2965017D1 (en) 1978-12-22 1983-04-14 Anvar New compounds associating peptidyl or aminoacyl residues to lipophilic groups and pharmaceutical compositions containing said new compounds
FR2446292A1 (fr) * 1979-01-12 1980-08-08 Anvar Muramyl-peptides fixes sur polymeres peptidiques et medicaments les contenant
FR2449697A1 (fr) 1979-02-20 1980-09-19 Anvar Nouveaux muramyl-peptides substitues sur un azote peptidique et medicaments les contenant
JPS5618996A (en) * 1979-06-21 1981-02-23 Dai Ichi Seiyaku Co Ltd Muramyldipeptide derivative
DK156252C (da) * 1979-07-31 1989-12-18 Fujisawa Pharmaceutical Co Analogifremgangsmaade til fremstilling af di-, tri- eller tetrapeptidderivater eller salte deraf
US4406889A (en) 1980-02-15 1983-09-27 Ciba-Geigy Corporation Derivatives of aldohexoses, intermediates, processes for their manufacture, preparations containing such compounds, and their use
EP0038153A3 (en) * 1980-04-15 1982-12-22 Beecham Group Plc Modified allergens
US4368190A (en) * 1980-04-17 1983-01-11 Merck & Co., Inc. Immunologically active dipeptidyl 4-O-,6-O-acyl-2-amino-2-deoxy-D-glucose derivatives and methods for their preparation
US4497729A (en) * 1980-12-01 1985-02-05 Fujisawa Pharmaceutical Co., Ltd. Peptide, process for preparation thereof and use thereof
FR2522967B1 (fr) * 1982-03-15 1986-03-07 Anvar Conjugues d'haptenes et de muramyl-peptides, doues d'activite immunogene et compositions les contenant
US4587046A (en) * 1982-05-18 1986-05-06 The Regents Of The University Of California Drug-carrier conjugates
FR2558165B1 (fr) * 1984-01-17 1986-07-04 Anvar Nouveaux conjugues d'oligo-muramylpeptides et compositions biologiques les contenant pour l'activation des macrophages
FR2569984B1 (fr) * 1984-09-12 1987-08-14 Anvar Molecule synthetique contenant une pluralite d'epitopes distincts, procede pour son obtention et application a la production de polyvaccins
WO2017190145A1 (en) 2016-04-29 2017-11-02 Icahn School Of Medicine At Mount Sinai Targeting the innate immune system to induce long-term tolerance and to resolve macrophage accumulation in atherosclerosis
EP3636656A4 (en) 2017-06-09 2021-04-14 Chugai Seiyaku Kabushiki Kaisha METHOD OF SYNTHESIS OF PEPTIDE WITH N-SUBSTITUTED AMINO ACID
CN119143631A (zh) * 2018-11-30 2024-12-17 中外制药株式会社 用于肽化合物或酰胺化合物的脱保护方法和在固相反应中的树脂脱除方法以及用于生产肽化合物的方法
CN118459539B (zh) 2021-03-19 2026-01-06 生物治疗探索股份有限公司 用于调节训练免疫的化合物及其使用方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH564031A5 (es) * 1968-03-29 1975-07-15 Anvar
US4186194A (en) * 1973-10-23 1980-01-29 Agence Nationale De Valorisation De La Recherche (Anvar) Water soluble agents effective as immunological adjuvants for stimulating, in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents
CH613709A5 (en) * 1975-12-10 1979-10-15 Ciba Geigy Ag Process for the preparation of glucosamine derivatives
GB1573126A (en) * 1976-03-10 1980-08-13 Anvar Immunising and anti-infectious adjuvant agents comprising peptide derivatives of muramic acid
FR2343482A1 (fr) * 1976-03-10 1977-10-07 Anvar La 2- (2-acetamido-2-deoxy-3-o-d-glucopyranosyl) -d-propionyl-l-seryl-d-isoglutamine et medicaments la contenant

Also Published As

Publication number Publication date
AU527549B2 (en) 1983-03-10
IL56724A0 (en) 1979-05-31
DD141616A5 (de) 1980-05-14
FI790584A7 (fi) 1979-08-25
FI66878B (fi) 1984-08-31
HU182011B (en) 1983-12-28
NO151088B (no) 1984-10-29
EP0003833B1 (de) 1983-07-20
ATA142079A (de) 1981-04-15
NO151201B (no) 1984-11-19
AR223833A1 (es) 1981-09-30
AU4454679A (en) 1979-08-30
GR77615B (es) 1984-09-25
JPH0130809B2 (es) 1989-06-22
EP0003833B2 (de) 1990-12-19
PL213696A1 (es) 1980-07-14
IL56724A (en) 1982-12-31
NO793993L (no) 1979-08-27
NZ189756A (en) 1982-05-31
NO790626L (no) 1979-08-27
GB2015534A (en) 1979-09-12
AT364718B (de) 1981-11-10
DK161026C (da) 1991-10-28
FI66878C (fi) 1984-12-10
ZA79893B (en) 1980-03-26
DK79779A (da) 1979-08-25
DK161026B (da) 1991-05-21
EP0003833A2 (de) 1979-09-05
SU1055312A3 (ru) 1983-11-15
EP0003833A3 (en) 1980-02-06
JPS54141718A (en) 1979-11-05
NO151201C (no) 1985-02-27
PL123315B1 (en) 1982-10-30
CA1138436A (en) 1982-12-28
PT69281A (de) 1979-03-01
NO151088C (no) 1985-02-06
ES477977A1 (es) 1980-01-16

Similar Documents

Publication Publication Date Title
MA20834A1 (fr) Vernis a ongle
ES422001A1 (es) Un procedimiento para la preparacion de nuevas imidazotria-zinas.
JPS5212120A (en) Non mixable odorless catalyst for synthesis of polyurethane
AR205506A1 (es) Asiento suspendido elasticamente para vehiculo
FR2463801B1 (fr) Dispositif pour le traitement de gaz de synthese obtenu par la gazeification de charbon
AU555418B2 (en) Muramyl peptides
ES470738A1 (es) Procedimiento para la obtencion de nuevos derivados de ni- trosourea
DK299584D0 (da) Hidtil ukendte prostacyklinderivater, fremgangsmaade til deres fremstilling og deres anvendelse som laegemidler
SE7704319L (sv) Basiskt substituerade xantinderivat
ZA761020B (en) 200276761020 system for diminishing the emission of noxious gases
IT1200582B (it) Odorizzante per la odorizzazione di combustibili gassosi inodori
DE3882106D1 (de) Aminogruppen enthaltende alkenylbernsteinsaeureester.
ES2016931B3 (es) Procedimiento de preparación de nuevas amidas alifáticas y cicloalifáticas de piridilalquilaminas o de sus derivados N-óxidos.
AU576477B2 (en) 5-fluoro-carbacyclins
NO870077L (no) Nye tyroninderivater.
ES471872A1 (es) Un procedimiento de preparacion de tetrahidro-s-triazin-tio-nas acaricidas
NO922304D0 (no) Eliminering av aktiverte lymfocytter
GR38288B (el) Μεθοδος δια την παρασκευην τρικυκλικων παραγωγων του ακεταμιδιου.
ES2007666A6 (es) Procedimiento para preparar derivados de isoquinolina y composiciones farmaceuticas correspondientes.
ES418728A1 (es) Procedimiento para la elaboracion de indolilalquilamina.
GB1080743A (en) Process for the preparation of substituted 5,6-dihydro-ª‡-pyrones
DK0599732T3 (da) 1-phenylbicyklo 2.2.2 octanderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem.
IT1214534B (it) 4-cloro-arilossi-acetil-e 4-cloro-arilossi-propionil-malonati aventi proprieta' erbicide.
ES293327A1 (es) Procedimiento para la fabricacion de nuevos derivados de 3-alfa-fenil-granatano
IT7422167U1 (it) Innesti per impianti